On Jun 03, 2026, MMED reported earnings of -0.68 USD per share (EPS) for Q4 26, missing the estimate of -0.17 USD, resulting in a -291.93% surprise. Revenue reached 837.00 million, compared to an expected 843.79 million, with a -0.80% difference. The market reacted with a +15.94% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.